✦ LIBER ✦

Characterization and antithrombotic action of tissue plasminogen activator

✍ Scribed by D. Bergqvist; I. M. Nilsson; M. Pandolfi

Book ID: 105414478
Publisher: Springer
Year: 1984
Tongue: English
Weight: 312 KB
Volume: 40
Category: Article
ISSN: 1420-682X
DOI: 10.1007/bf01959105

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Physical characterization of recombinant

Physical characterization of recombinant tissue plasminogen activator

✍ Sarkis S. Margossian; Henry S. Slayter; Elzbieta Kaczmarek; Jan McDonagh 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 971 KB

New mechanisms of action for tissue-type

New mechanisms of action for tissue-type plasminogen activator?

✍ Allan S. Jaffe 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Tissue Activator of Plasminogen

✍ LACK, CHARLES H.; YOUSUF ALI, S. 📂 Article 📅 1964 🏛 Nature Publishing Group 🌐 English ⚖ 266 KB

Effect of oral defibrotide on tissue-pla

Effect of oral defibrotide on tissue-plasminogen activator and tissue-plasminogen activator inhibitor balance

✍ F. Violi; D. Ferro; M. Saliola; C. Quintarelli; S. Basili; F. Balsano 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 491 KB

Defibrotide, a polydeoxyribonucleotide of mammalian origin, has been shown to reduce the blood level of the plasminogen activator inhibitor, and so to increase the activity of tissue plasminogen activator without any adverse effect. A randomized, double-blind, placebo-controlled study has been done

Neurotoxicity of tissue plasminogen acti

Neurotoxicity of tissue plasminogen activator

✍ Kathleen Wildasin 📂 Article 📅 2004 🏛 The Lancet 🌐 English ⚖ 41 KB

Tissue-plasminogen activator, plasminoge

Tissue-plasminogen activator, plasminogen activator inhibitor and risk of peripheral arterial disease

✍ Felicity B Smith; Amanda J Lee; Ann Rumley; F Gerald; R Fowkes; Gordon D.O Lowe 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 724 KB